期刊文献+

肿瘤标志物联合检测对胸腔积液的诊断价值 被引量:1

下载PDF
导出
摘要 目的:评价多项肿瘤标志物联合检测对胸腔积液的诊断价值。方法:采用化学发光免疫分析法测定胸腔积液112例CA125、CA19-9、CA15-3及CEA水平,对结果进行综合分析。结果:恶性组CA15-3、CA19-9及CEA均明显高于结核组及良性组(P<0.01);恶性组与结核组CA125均明显高于良性组(P<0.01);4项肿瘤标志物联检对恶性胸腔积液的敏感性为81.6%、特异性为95.2%、诊断准确性为89.3%。结论:肿瘤标志物联合检测对胸腔积液具有一定诊断价值。
机构地区 空军总医院
出处 《人民军医》 2008年第12期789-790,共2页 People's Military Surgeon
  • 相关文献

参考文献5

  • 1[1]Poreel J,Vives M,Esquerda A,et al.Use of Pand of markers in pleural fluid for differential diagnosis of benign and malignant effusion[J].J Chest,2004,126:1 751-1 763.
  • 2徐宁,黄小萍.CA125对恶性和结核性胸腔积液的鉴别意义[J].浙江中西医结合杂志,2005,15(3):155-156. 被引量:5
  • 3[4]Lee J H,Chang JH.Diagnostic utility of serum and pleural fluid carcinoembryonic antigen,neuron-specific enolase,and cylokeratin 19 fragments in patients with effusions from primary lung cancer[J].Chest,2005,128(4):2 298-2 303.
  • 4[5]Porcel JM,Vives M,Esquerda A,et al.Use of a panel of tumor markera (carcinoembryonic antigen,cancer antigen 125,carbohydrate antigen 15-3,and cytokeratin 19 fragments)in pleural fluid for the differential diagnosis of benign and malignant effuaiona[J].Chest,2004,126 (6):1 767-1 763.
  • 5邹大伟,张斌,巴静,叶千红,吴广平.肺癌患者胸腔积液中CEA及CA153的表达及意义[J].中国肺癌杂志,2006,9(4):337-339. 被引量:10

二级参考文献15

  • 1王自正 时宏珍 等.实用临床RIA和PCR检测[M].北京:人民卫生出版社,1995..
  • 2Kabawatt SE,Basterc Jr,Bhan AK,et al. Tissue distribution of coelomic epithelium related antigen recognize by monoclonal antibody CA125. Int J Gynecol,1984,2:275-285.
  • 3Ronay G,Jager W,Tulusan AH. Immunohistochemical and serologic detection of CA125 in patients with peritoneal tuberculosis and ascites. Geburtshilfe Frauenheilkd,1989,49:61-63.
  • 4Shitrit D, Zingerman B, Shitrit AB, et al. Diagnostic value of CYFRA 21 1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist,2005,10(7) : 501-507.
  • 5Fuhrman C, Duche JC, Chouaid C, et al. Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem,2000,33(5) : 405-410.
  • 6Alatas F, Alatas O, Metintas M, et al. Diagnostic value of CEA,CA 15 3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. Lung Cancer,2001,31(1) : 9 16.
  • 7Miedouge M, Rouzaud P, Salama G, et al. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer,1999,81(6) : 1059-1065.
  • 8Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non small cell lung cancer. Anticancer Res,2001,21(4B) : 3085-3092.
  • 9Kulpa J, Wojcik E, Reinfuss M, et al. Carcinoembryonic antigen,squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem, 2002,48(11):1931-1937.
  • 10Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest,2004,126(6) : 1757-1763.

共引文献13

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部